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PURPOSE. To analyze the levels of the diadenosine polyphos-
phates Ap4A and Ap5A in tears, in a set of control subjects and
in groups of symptomatic and nonsymptomatic persons with
dry eye.
METHODS. Ninety-seven subjects participated in the study. The
subjects were divided into five experimental groups: control
subjects; symptomatic patients with normal tear secretion;
symptomatic patients with low tear secretion; forced blink;
and corneal mechanical stimulation provided by a gas esthesi-
ometer. The Schirmer I test was used to measure and collect
tear secretions from each subject. All samples were processed
by high pressure liquid chromatography (HPLC) and their
Ap4A and Ap5A levels determined.
RESULTS. The levels of Ap4A and Ap5A in tears were greater in
all symptomatic patients than in control subjects, especially in
symptomatic subjects with low tear secretion. Within the
symptomatic subjects with normal tear secretion, significant
differences in concentrations of Ap4A and Ap5A were found
between men and women. In the forced blink experiments,
concentrations of the Ap4A and Ap5A rose with increasing
blink frequency. When the cornea was mechanically stimu-
lated, the levels of Ap4A and Ap5A rose significantly during
both moderate and high-flow rate tests.
CONCLUSIONS. The increased levels of Ap4A and Ap5A in tears of
patients with dry eye allow these dinucleotides to be used as
objective biomarkers in dry eye conditions. (Invest Ophthal-
mol Vis Sci. 2006;47:4053–4058) DOI:10.1167/iovs.05-0980
The tear film constitutes a moist natural barrier that sepa-rates the eye from the external media. This consistent film
is formed mainly by a triplet of aqueous, mucous, and lipid
layers that provide the necessary equilibrium for maintaining
the health of the ocular surface.1 The principal functions of
this film are: (1) to keep the ocular surface wet and well
lubricated; (2) to transfer the nutritional elements to the cor-
nea, (3) to eliminate foreign matter and cellular debris gener-
ated on the ocular surface by the tear flow and the blink
process; and (4) to act as the first line of defense against ocular
surface infections.2
The balance between the composite layers of the tear film
is critical, and when altered it can give rise to complications on
the ocular surface. These complications are widely known as
dry eye–related problems, the severity of which depends on
the level of imbalance. Two causes of this disequilibrium are a
deficiency in tear secretion caused by Sjo¨gren’s syndrome, or
tear film instability due to the wearing of contact lenses. Signs
and symptoms of these complications can vary from patient to
patient, often with little or no correlation between them.
Patients may present with low tear secretion volume, ocular
signs, and no ocular symptoms or with normal tear volume and
ocular symptoms of dryness. This poor correlation is well
known, having been frequently reported in the literature.3–5
This ambiguity in etiology and pathophysiology6 can make a
precise diagnosis difficult.
Today, there are several questionnaires and tests designed
to evaluate patients’ signs and symptoms. Among these tests,
the National Eye Institute/Industry Dry Eye Workshop7 pro-
posed the combined use of a validated questionnaire regarding
symptoms, a test to evaluate ocular surface damage, measure-
ment of tear instability, and the demonstration of tear hyper-
osmolarity.
More recently, the second National Eye Institute/Industry
Workshop on Clinical Trials has given rise to new criteria for
subjective and objective testing for dry eye, and several tests,
both invasive and noninvasive, are now emerging.8 These tests
are designed to identify and analyze biomarker profiles in tears
to detect clearly whether an individual has dry eye. The iden-
tification of a stable molecule present in tears whose concen-
tration changes with different dry eye conditions, would make
diagnosis, follow-up, and the assessment of dry eye treatments
both easier and more precise.
Pintor et al.9 have described the presence of a new family of
compounds in the tear film, the diadenosine polyphosphates.
These compounds, are naturally occurring dinucleotides, ex-
hibiting both intracellular and extracellular physiological ef-
fects10,11 Formed by two adenosine molecules joined by a
variable phosphate chain, they are abbreviated as ApnA (n 
2–7). Although the activity of these nucleotides in ocular tis-
sues has not been fully investigated, it is known that they act
through P2 receptors to modulate intraocular pressure in rab-
bits12; Ap4A and UTP improve the rate of wound healing in the
cornea of New Zealand White rabbits13; Ap4A, Ap5A, and Ap6A,
can stimulate tear secretion after single-dose topical applica-
tion in rabbits.14
In this study, the levels of diadenosine polyphosphates in
tear secretions were examined in a group of control subjects
without any symptom of ocular dryness and with a normal
volume of tear secretion, as well as two groups of dry eye
symptomatic subjects, one with low tear secretion volume and
another with normal tear volume. Secretion of the dinucleo-
tides was also examined in forced blink experiments and after
moderate and strong corneal mechanical stimulation using a
gas esthesiometer. Analysis of the resultant data suggests that
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these substances, in particular Ap4A, can act as a tear film
molecular marker for dry eye states. Preliminary results have




Ninety-seven subjects of both sexes (27 men and 70 women, of age
ranging from 20 to 36 years with a mean age of 27  1 years)
participated voluntarily in the study. The research was in compliance
with the tenets of the Declaration of Helsinki. The subjects signed an
informed consent and were free to interrupt the session at any time.
The McMonnies15 test was performed to detect possible symptoms of
ocular dryness.
As identified by the McMonnies test, all nonsymptomatic subjects
(n  51), had a Schirmer I test16 result equal to or greater than 10 mm.
This population was then divided into three groups: those who would
participate in the forced-blink experiment (n  8), those who would
take part in the esthesiometer measurements (n  6), and a control
group (n  37).
Symptomatic subjects (n  46), again as identified by the McMon-
nies test, were divided into two groups: symptomatic subjects with
normal tear secretion (n  34), those who presented symptoms of
ocular dryness and had a Schirmer I test result 10 mm; symptomatic
subjects with low tear secretion (n  12), those who exhibited
symptoms but whose tear secretion measured with the Schirmer I test
was 5 mm.
The distribution of subjects and McMonnies scores for the different
groups are summarized in Table 1.
Trials
Tear Collection. Tear secretion was measured in all groups with
the Schirmer I test. In control group and symptomatic subjects, the
Schirmer strip was located on the temporal tarsal conjunctiva of the
lower lid for 5 minutes with the eyes closed. Secretion was measured
without any kind of stimulation.
Forced-Blink Experiment. Schirmer trips were located at the
temporal tarsal conjunctiva of the lower lid of eight nonsymptomatic
subjects with normal tear secretion. The patients were instructed to
blink at 0, 12, 30, and 60 blinks per minute during 5 minutes.
Esthesiometry Experiment. Schirmer strips were located at
the temporal tarsal conjunctiva of the lower lid of six nonsymptomatic
subjects with normal tear secretion for 5 minutes after the corneal
stimulation. The cornea was mechanically stimulated with a gas esthe-
siometer.17 Three gas pulses, each lasting 3 seconds, were applied
sequentially (interval, 0.5 seconds) to the center of the cornea. Two
flow rates of mechanical stimulation were applied: moderate (170
mL/min) and high (260 mL/min) flow.18 Subjects were asked to avoid
blinking during the application of the three gas pulses.
In all groups, the volume of tears, measured as millimeters of
moistened Schirmer strip, was recorded and the strips placed in tubes
(Eppendorf, Fremont, CA) containing 500 L of ultrapure water. The
tubes were then frozen until HPLC analysis was performed.
Sample Processing and HPLC Analysis
Schirmer strips were collected, placed in Eppendorf tubes containing
500 L of ultrapure water, and strongly vortexed for 5 minutes. The
strips were carefully rinsed and the liquid in the tube was heated in a
100°C bath for 20 minutes to precipitate proteins. The tubes were
centrifuged at 4000 rpm for 30 minutes to form a pellet of the proteins.
Diadenosine polyphosphates are resistant to this treatment, as demon-
strated by Pintor et al.19 The supernatants were chromatographed
(SEP-PAK Accell QMA cartridges; Waters, Milford, MA).20 Briefly, 250
L of the supernatant was passed through the cartridges which had
been equilibrated with 3 mL of ultrapure water. The elution of the
nucleotides and dinucleotides was performed by applying 1 mL of a
solution containing 0.2 M KCl and 0.1 M HCl, and the samples were
neutralized with KOH. The eluents were then injected at a volume of
10 to100 L into the HPLC for analysis.
Determination and quantification of diadenosine polyphosphates
were performed by HPLC. The chromatographic system consisted of a
isocratic HPLC pump (model 1515; Waters), a dual absorbance detec-
tor (2487; Waters), and an injector (Reodyne, Rhonert Park, CA), all
managed by the software (Breeze) and a column from Waters (15 cm
length, 0.4 cm diameter; Novapack C18).
The system was equilibrated overnight with the following mobile
phase: 0.1 M KH2PO4, 2 mM tetrabutyl ammonium, and 17% acetoni-
trile (pH 7.5).19 Detection was monitored at a 260-nm wavelength, and
all the peaks identified as putative dinucleotides were taken for phos-
phodiesterase treatment. Phosphodiesterase from Crotalus durissus,
from Sigma-Aldrich (St. Louis, MO; EC 3.1.15.1.) at a concentration of
0.3 U/mL was incubated for 10 minutes with the corresponding puta-
tive dinucleotide. The digestion products were analyzed by HPLC.
Peaks were transformed into concentrations by means of external
commercial diadenosine polyphosphates standards of known concen-
trations.
Statistical Analysis
The data are presented as the mean SD of results of the experiments.
Data were analyzed with Student’s t-test, and significance was set at
P  0.05.
RESULTS
Ap4A and Ap5A Levels for the Control Group and
Symptomatic Subjects
Pintor et al.9 identified the presence of diadenosine poly-
phosphates in human tears; however, little is known about the
levels of concentration in the tears of individuals presenting
with ocular dryness. The levels of these substances in both
normal and pathologic eyes were therefore investigated in the
present study.
Two peaks were tentatively identified as Ap4A and Ap5A,
according to the HPLC retention times (Fig. 1A). To confirm
that these peaks corresponded to Ap4A and Ap5A, they were
individually collected and treated with phosphodiesterase from
Crotalus durissus (Figs. 1B, 1C). The treatment of the putative
Ap4A produced two peaks after the enzyme action, identified
TABLE 1. Distribution of McMonnies Scores in the Different Groups
Control








Number 37 8 6 34 12
Women/men 24/13 6/2 4/2 24/10 12/0
Scores 5.1  2.2 5.1  2.4 8.1  2.1 13.3  2.1 12.8  1.6
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as AMP and ATP, whereas the putative Ap5A yielded AMP and
adenosine tetraphosphate (Ap4). These results indicate that the
two peaks did indeed correspond to Ap4A and Ap5A. Compar-
ison of the strength of these peaks with known standards
permitted quantification of the concentration of the two
dinucleotides in the samples (Fig. 1D). In the control group,
the concentrations observed for diadenosine tetraphosphate
and diadenosine pentaphosphates were 0.107  0.291 and
0.036  0.030 M, respectively (n  37; Fig. 2).
Relative to the control group, the symptomatic group with
low tear secretion showed a marked increase in diadenosine
polyphosphate concentrations, statistically to a 95% or greater
confidence level (Fig. 2), their concentrations being 10.68 
1.87 M for Ap4A and 12.45  0.290 M for Ap5A (n  12).
The concentrations of these dinucleotides in the symptomatic
subjects with normal tear secretion, exhibited similar, though
less marked, variations in the dinucleotide levels (Fig. 2). The
concentrations of Ap4A and Ap5A in these cases were 0.590 
0.330 and 0.058  0.017 M, respectively (n  34).
A potentially significant observation was made when the
sex of the subject was factored in to these results. Whereas the
control group exhibited no significant variance in concentra-
tion with sex, the sample of symptomatic women with normal
tear secretion appeared to present higher levels of diadenosine
polyphosphates than did that of men. Symptomatic women
presented Ap4A levels of 0.796  0.330 M (P  0.001),
whereas symptomatic men exhibited concentrations of
0.384  0.172 M for the same dinucleotide. Concerning the
levels of Ap5A, symptomatic women presented concentrations
of 0.069  0.031 M and symptomatic men of 0.047  0.015
M (P  0.037). It was not possible to repeat this observation
for the low tear volumes, however, because all patients in this
group were female. The potential divergence gives rise to the
possibility that there may be a hormonal factor involved, which
may bear further investigation. These mentioned divergences
open the possibility of performing future studies to see
whether hormonal factors could be responsible for such vari-
ability.
Ap4A and Ap5A Levels and Forced Blinking
Tsubota et al.21 reported that patients with dry eye can in-
crease their blink rate to compensate for tear instability. Ac-
cordingly, in this study, the effect of forced blinking on levels
of diadenosine polyphosphates in the tear film was examined.
Eight subjects with no symptoms of ocular dryness and a
normal volume of tear secretion participated in the experi-
ment. Variations in Ap4A and Ap5A concentrations in their
tears were investigated for four different blink frequencies: 0,
12, 30, and 60 blinks per minute, with 0 blinks per minute
(eyelids closed) being considered the control for this experi-
ment.
The chromatographic analysis revealed substantial changes
in the concentrations of Ap4A and Ap5A with differing blink
frequency (Fig. 3A). When these peaks were transformed into
concentrations, the levels of Ap4A rose from 0.109 0.081 M
for 0 blinks/min to 2.853  0.394 M at 60 blinks/min (Fig.
3B). An almost identical trend was observed for Ap5A, with
concentrations rising from 0.041 0.050 M (0 blinks/min) to
2.091 0.065 M at 60 blinks/min (Fig. 3B). It was possible to
observe a gradual increase in the dinucleotide concentration
concomitant with the increase in the blink frequency.
The augmented concentrations of Ap4A and Ap5A for the
different blinking frequencies paralleled an increase in tear
secretion. These results are shown in Figure 4 in which an
increase in the Schirmer scores occurred with the increase in
frequency of the forced blink.
Ap4A and Ap5A Levels for the
Esthesiometry Experiments
The forced blink experiments demonstrated a clear increase in
the tear concentrations of Ap4A and Ap5A with increasing blink
frequency. This increase could be due to the shear stress
produced by the eyelids on the corneal surface. Srinivas et al.22
described how the mechanical action of the eyelids on the
ocular surface can provoke a shear stress at the corneal epi-
thelial cells and subsequently a release of intracellular sub-
stances to the tears including nucleotides and dinucleotides.22
One question that arises is whether the release of nucleotides
FIGURE 2. Concentrations of diadenosine polyphosphates in tears in
normal and dry eye conditions. Individuals with no symptoms and
normal tear secretion (control subjects) were compared with symp-
tomatic patients with either low or normal tear secretion. In all the
cases, the dinucleotide concentrations were higher in the symptomatic
group than in the control group. In the group of symptomatic normal
tear secretors, Ap4A but not Ap5A, was significantly higher than in the
control group. Data from both eyes were pooled and are expressed as
the mean  SD. ***P and ###P  0.0001; paired t-test.
FIGURE 1. Diadenosine polyphosphate detection in tears. (A) Chro-
matographic profile of a sample obtained and processed, showing the
presence of two peaks identified as Ap4A and Ap5A. (B) Rechromatog-
raphy of the Ap4A peak shown in (A), after treatment with phospho-
diesterase. The reduction in the dinucleotide peak is concomitant with
the appearance of the hydrolytic products AMP and ATP. (C) Rechro-
matography of the Ap5A peak shown in (A) after treatment with
phosphodiesterase. The reduction in the dinucleotide peak is concom-
itant with the appearance of the hydrolytic products AMP and Ap4. (D)
Standard injection of commercial adenine mono- and dinucleotides.
IOVS, September 2006, Vol. 47, No. 9 Diadenosine Polyphosphates in Dry Eye 4055
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/933235/ on 10/21/2016
is simply a product of this shear stress, or whether it is trig-
gered by mechanical stimulation of corneal nerve terminals. To
investigate this, a gas esthesiometer was used to reproduce the
mechanical stimulation.
Six subjects participated in this part of the study, all show-
ing a normal volume of tear secretion and none presented
symptoms of ocular dryness according to the McMonnies test.
Tears were collected after application of the mechanical stim-
uli, and the diadenosine polyphosphates were isolated and
quantified by HPLC.
The concentrations of diadenosine polyphosphates were
found to be statistically independent (95% confidence) of the
intensity of the mechanical stimulus applied (Fig. 5). Both
moderate (170 mL/min) and high (260 mL/min) mechanical
stimulation of the corneal nerves, resulted in a significantly
greater amount of dinucleotides than that in the control sub-
jects (n  6). The moderate mechanical stimulus produced
tear concentrations of 0.170  0.012 and 0.058  0.073 M
for Ap4A and Ap5A, respectively. The Ap4A and Ap5A concen-
tration for the high mechanical stimulus were 0.163  0.048
and 0.065  0.007 M, respectively (Fig. 5). Even the moder-
ate mechanical stimulus, which may be of the same intensity as
provoked by the eyelids during the blinking process and not
strong enough to stimulate the majority of corneal polymodal
and mechanonociceptors, resulted in increased concentrations
of diadenosine polyphosphates in tears.
DISCUSSION
The results show that patients with symptomatic dry eye with
a reduced tear secretion have greatly elevated levels of the
adenosine dinucleotides Ap4A and Ap5A in their tears, being
increased 100- and 345-fold for Ap4A and Ap5A, respectively.
Symptomatic patients with normal tear secretion also demon-
strated an increase in diadenosine polyphosphate concentra-
tions, although not as marked as those with low tear produc-
tion. These concentrations of Ap4A and Ap5A were increased 5-
and 1.5-fold, respectively.
Furthermore, a difference between the sexes was evident.
Symptomatic women with normal tear secretion presented
higher values of diadenosine polyphosphates than did similar
men. However, there was no significant difference between
the sexes in the control group. This result suggests that the sex
of a patient should be taken into account as well as the
measure of diadenosine levels in tears, in a specific test to
determine borderline dry eye disease.
FIGURE 4. Volume of tear secretion measured by Schirmer I test for
the different frequencies (bpm) of blinking. The Schirmer test results
increased with the increase in the blink rate. Data from both eyes were
pooled and are expressed as the mean  SD. **P  0.0003 for 30 bpm
and 60 bpm, paired t-test.
FIGURE 5. Effect of mechanical stimulation of the cornea with a gas
esthesiometer on diadenosine polyphosphate levels in tears. Diade-
nosine polyphosphates increased in concentration in tears after both
moderate and high corneal mechanical stimulation when compared
with the control. Data from both eyes were pooled and are expressed
as the mean  SD. *P  0.05, paired t-test.
FIGURE 3. Levels of diadenosine polyphosphates after different blink-
ing frequencies. (A) HPLC eluting profiles of tear samples after 0, 12,
30, and 60 blinks per minute. An increase in the concentration of Ap4A
and Ap5A was observed with the increase in the blinking frequency.
(B) Quantification of the diadenosine polyphosphate levels in individ-
uals blinking at different frequencies. As occurred in (A), there was a
gradual increase in the concentration of Ap4A and Ap5A with the
frequency of blinking. Data from both eyes were pooled and are
expressed as the mean  SD. ***P and ###P  0.0001 and *P  0.05;
paired t-test.
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Because it has been shown that Ap4A and Ap5A stimulate
tear secretion,14 it was unexpected to see patients with low
tear secretion having increased concentrations of these
dinucleotides. It appears that although Ap4A and Ap5A are
plentiful, they are not able to stimulate lacrimation, and it
could be that in those patients, dry eye is a consequence of a
lacrimal gland malfunction. The mechanism of action of the
dinucleotides is not fully understood. Possibly, they increase
tear production by stimulating corneal and conjunctival water
and electrolyte production, by causing vasodilatation of con-
junctival blood vessels, or by inducing conjunctival goblet cell
secretion or increasing meibomian gland secretion. In aqueous-
deficiency dry eye, one or more of these processes could be
defective, and thus tear volume could be decreased even in the
presence of increased levels of Ap4A and Ap5A.
In the symptomatic normal tear secretion dry eye group,
tear composition, rather than volume, could be altered causing
the symptoms. Dinucleotides present in tears could be stimu-
lating tear secretion, and although the tears are defective, they
are produced in normal amounts because of the increased
levels of Ap4A and Ap5A. More work is needed to clarify this
point.
The mechanism by which diadenosine polyphosphates and
other nucleotides such as ATP enter the extracellular fluid has
not yet been identified. It is possible, as occurs in the central
nervous system, that nucleotides are liberated from nerve ter-
minals, but there is evidence that nucleotides can be trans-
ported out of cells. Epithelial cells,23,24 and in particular ocular
epithelial cells,25 use different transport mechanisms as a reg-
ulated procedure for nucleotide release. The ATP binding cas-
sette (ABC) transporter, the cystic fibrosis transmembrane con-
ductance regulator (CFTR), or glycoprotein P have been
proposed as elements involved in the release of nucleo-
tides.26–28 Gomes et al.29 have described that ATP leaves cor-
neal endothelial cells by means of connexin hemichannels
when these cells are stimulated mechanically. It would there-
fore not be surprising that a mechanism of release takes place,
although experiments to test this are outside the scope of the
present study.
The forced blinking experiments replicate a natural shear
stress, and the elevated levels of dinucleotides as a result of
increased frequency of blinking are indicative of mechanically
stimulated release. It is known that ocular surface conditions
can affect the pattern of blinking and that patients with dry
eye–related problems can increase their blink rate to compen-
sate for tear instability or deficiency. Tsubota et al.21 described
a blink rate of 34 blinks per minute in subjects with dry eye,
compared with a normal blinking rate of 10 to 15 blinks per
minute, which has been described as an essential, involuntary
action for the protection of the ocular surface.30,31
The elevated levels of dinucleotides in patients with dry eye
is compatible with an increased rate of blinking. Patients with
dry eye and low tear secretion had values of Ap4A and Ap5A of
1.14 and 0.91 M respectively, which were comparable to
levels recorded in normal subjects forced to blink at 30 per
minute. This suggests that an increase in dry eye symptoms
followed by an increase of the blinking rate could also produce
an enhancement of the Ap4A and Ap5A tear concentrations,
and indicate that the appearance of these dinucleotides de-
pends only on the rate of mechanical stimulation, and seems to
be independent of tear secretion.
The relationship between the amounts of diadenosine
polyphosphates and the blink rate, probably due to the friction
of the eyelids on the ocular surface, seems to be clear. The gas
esthesiometer17 permitted us to apply mechanical stimuli with
air at different intensities, close or over the stimulation thresh-
old of corneal nerves. This reveals whether these compounds
are released as a consequence of mechanical corneal nerve
stimulation.
Acosta et al.18 described that only strong stimulation (high
mechanical intensity, chemicals, or severe cold) of corneal
nerves increases tear secretion, which explains that chiefly
stimulation of polymodal corneal sensory nerves evokes reflex
tear secretion. Although both moderate and high mechanical
stimuli stimulate corneal nerves, high-intensity stimuli recruits
a larger population of nerves.32 The esthesiometer experi-
ments performed showed a small but significant increase in
diadenosine polyphosphate levels after both moderate and
strong mechanical stimuli. The lack of difference between the
two mechanical stimuli indicates that at least a part of the
dinucleotide release is independent of neural stimulation and
should respond to the effect of the mechanical force applied to
the corneal epithelium. Acosta et al.18 reported that a strong
stimulus increases tear secretion and also evokes a sensation of
irritation that may induce a reflex tear secretion and blinking.
This sensation appears more frequently in patients with dry
eye and therefore the frequency of blinking is increased.21 It is
apparent that the blinking process provides ocular protection
and contributes to spreading the tear film over the ocular
surface. If there is a deficient or unstable tear film, the evapo-
ration rate as well as the necessity of blinking increase. The
increase in blinking can induce a shear stress on the ocular
surface and, moreover, this fact can lead to raised levels of
nucleotides in tears. It has been suggested that these sub-
stances, Ap4A and Ap5A, have a role in the stimulation of tear
secretion,14 and it appears that they are naturally released to
try to increase the tear volume/quality stimulating P2Y2 recep-
tors present in meibomian and accessory glands.33 Moreover,
because these substances are in any case increased in dry eye,
we would like to suggest that these dinucleotides may be used
as markers for dry eye conditions.
In summary, the levels of diadenosine polyphosphates in
tears were analyzed in different groups of patients with dry
eye. The group of symptomatic subjects with low tear secre-
tion as well as the symptomatic subjects with normal tear
secretion presented higher levels of diadenosine polyphos-
phates in tears than did the control subjects. In addition,
significant differences were found between men and women
and in this symptomatic group, the levels being higher in
women. Besides symptomatology, other possible aspects re-
lated to dry eye, such as blinking frequency and corneal sen-
sitivity, have been taken into account. While the dinucleotide
levels were significantly increased concomitantly with the in-
crease in the blink rate, the contribution from the corneal
nerve stimulation was not so important.
These stable molecules could be an objective parameter for
scoring the severity of dry eye, the follow-up of the disease,
and to determine the efficacy of treatment.
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